Publication
The Risks of Self - Medication: Case Report of Familial Misuse of AM3 (Immunoferon®)
| dc.contributor.author | Oliveira, M | |
| dc.contributor.author | Neves, R | |
| dc.contributor.author | Abranches, M | |
| dc.date.accessioned | 2013-03-20T11:42:29Z | |
| dc.date.available | 2013-03-20T11:42:29Z | |
| dc.date.issued | 2010 | |
| dc.description.abstract | Over the last decades extended medical knowledge has been an important health care benefit in terms of disease prevention and management. However, probably with no exception, most pharmaceutical products are not devoid of adverse consequences. Immunomodulators are commonly considered a “benign” drug whose advantages bypass consequences. The immunomodulator AM3 (Immunoferon®) is a clinically used, orally administered compound whose active principle is stabilised in an inorganic matrix of calcium. We report the misuse of AM3 in three members of a family; father and two children. The drug was prescribed to the father who subsequently administered it to the children without seeking medical advice. Two months later, all subjects developed abdominal and/or flank colicky pain. Hypercalciuria was diagnosed in the children with different degrees of severity. It is likely that the calcium content of the inorganic matrix played an important role in the onset of symptoms. No adverse side effects related to the inorganic matrix of calcium of immunoferon® have been documented so far. This family case report calls attention to the risks of self -medication in a susceptible family. Paediatric patients are vulnerable as they rely on adults for the supply of medications. Concerning the use of drugs in family, especially nonprescription drugs, the quality of health care provided to the children depends on the health literacy of their parents. | por |
| dc.identifier.citation | Port J Nephrol Hypert 2010; 24(4): 301-303 | por |
| dc.identifier.uri | http://hdl.handle.net/10400.17/1183 | |
| dc.language.iso | eng | por |
| dc.publisher | Sociedade Portuguesa de Nefrologia e Hipertensão | por |
| dc.subject | Hipercalciúria | por |
| dc.subject | Immunoferon | por |
| dc.subject | Auto-Medicação | por |
| dc.subject | HDE NEF PED | |
| dc.title | The Risks of Self - Medication: Case Report of Familial Misuse of AM3 (Immunoferon®) | por |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 303 | por |
| oaire.citation.startPage | 301 | por |
| oaire.citation.volume | 24 | por |
| rcaap.rights | openAccess | por |
| rcaap.type | article | por |